SUMMARY Lymphocytotoxic antibodies are a common feature in the sera of patients with systemic lupus erythematosus. This family study, however, has not confirmed the previous findings of an increased incidence in the sera of their relatives. Adsorption studies suggest that when lymphocytotoxins occur in the sera of normal subjects and relatives of patients they have a different specificity and thus significance.
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Lymphocytotoxins have been found in a large number of conditions including viral illnesses,' malignancy,2 multiple sclerosis,3 organ transplantation, following pregnancy, and after a variety of immunising procedures including vaccination. 4 They are recognised to occur in high titre in patients with systemic lupus erythematosus (SLE) and to a less extent in rheumatoid arthritis.5 Since lymphocytotoxins occur in viral illness, though only for a short time, the concept has arisen that a virus or viruses may be of aetiological importance in SLE.6 Some family studies of patients with SLE examining the incidence of lymphocytotoxic antibodies in patients, and in consanguineous and nonconsanguineous contacts have demonstrated a significant increase in lymphocytotoxins in the latter 2 groups compared with normal control subjects.7 12 But other investigators have not confirmed these findings." 1 In order to elucidate further the incidence and nature of lymphocytotoxins in SLE, particularly with regard to their antigenic and temperature specificity, a family study has been undertaken.
Subjects and methods

SLE PATIENIS AND FAMILIES
Sixteen families in whom one individual met the ARA criteria"5 for classification of SLE were studied. In addition there were 15 other patients with SLE, whose families were not studied, making a total of 31 patients. All Analysis of the data for consanguineous and nonconsanguineous relatives of patients with SLE did not reveal any significant differences from the control. Three of the 4 patients with SLE whose relatives had lymphocytotoxins similarly were found to have lymphocytotoxins in their sera.
2. HLA tissue typing. Reactions of the sera were compared with those found with the HLA typing sera. There was no association between the cold lymphocytotoxins and any of the HLA specificities identified on the lymphocytes of the normal panel subjects.
3. Adsorption study. In one family both a patient and his sister had lymphocytotoxins in their sera. However, this patient's sister had her lymphocytotoxins adsorbed by platelets at both 4°C and 15°C. A control subject with lymphocytotoxins exhibited strong adsorption with platelets and adult RhO +ve red cells at both temperatures. Sera from patients with SLE tended to react with the majority of the adsorbing tissues (Table 2 ).
Discussion
The results of this study have confirmed the significantly increased incidence of lymphocytotoxic reactions in the sera of patients with SLE. However, an increased incidence of lymphocytotoxic reactions was not found in consanguineous and nonconsanguineous relatives of patients with SLE as reported by others.7'-0 12 A number of explanations could account for these differing results. In the present study the majority of patients had clinical evidence of disease activity when they were studied. Previous studies have given little indication of the type of clinical disease their patients suffered from as it has been reported that the highest cytotoxicity occurs in patients with CNS involvement.27 At least one study reported a very high incidence of lymphocytotoxins in the control groups as well as relatives. 10 This would suggest that there may be a high background of lymphocytotoxins of whatever aetiology in the sera of that community. Another study has reported a significant reduction in lymphocytotoxicity after adsorption with fetal cord red cells, and this was taken as evidence for predominantly i specificity in the sera of patients with SLE.29 However, in the present study the 3 sera from patients with SLE gave strong reactions with many different tissue antigens, and there was no evidence for predominant i activity. There was no evidence that the lymphocytotoxins had anti-HLA activity as had been reported previously."1
The lymphocytotoxins in the serum of a relative of a patient with SLE were totally adsorbed by the platelet extract. This is evidence that these lymphocytotoxins were not of the same aetiology as those found in the sera of patients with SLE.
In summary, this study has not found an increased incidence of lymphocytotoxins in the sera of close contacts of patients with SLE. When they did occur in a consanguineous relative the adsorption pattern was consistent with their being active against some blood group substance and not having broad reactivity, as was the case of the lymphocytotoxins found in the sera of patients with SLE. This is strong evidence against the lymphocytotoxins in the sera of relatives and patients with SLE having a common aetiology. 
